A detailed history of Grimes & Company, Inc. transactions in Elevance Health, Inc. stock. As of the latest transaction made, Grimes & Company, Inc. holds 422 shares of ELV stock, worth $209,923. This represents 0.01% of its overall portfolio holdings.

Number of Shares
422
Previous 416 1.44%
Holding current value
$209,923
Previous $215,000 6.05%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$497.49 - $547.8 $2,984 - $3,286
6 Added 1.44%
422 $228,000
Q1 2024

Apr 17, 2024

BUY
$464.61 - $519.96 $193,277 - $216,303
416 New
416 $215,000
Q4 2022

Jan 25, 2023

SELL
$465.23 - $546.77 $29,309 - $34,446
-63 Reduced 12.83%
428 $0
Q3 2022

Oct 28, 2022

BUY
$445.98 - $507.0 $7,135 - $8,112
16 Added 3.37%
491 $223,000
Q2 2022

Jul 22, 2022

SELL
$444.32 - $529.84 $2,221 - $2,649
-5 Reduced 1.04%
475 $229,000
Q4 2021

Feb 01, 2022

BUY
$370.08 - $467.67 $177,638 - $224,481
480 New
480 $222,000

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $119B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Grimes & Company, Inc. Portfolio

Follow Grimes & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.